N euroimmunoendocrinological aspects of arterial hypertension
https://doi.org/10.18705/1607-419X-2014-20-5-349-354
Abstract
Article presents the latest data on the role of the immune, endocrine and sympathetic nervous system in the pathogenesis of hypertension. The authors pay attention to the interaction of regulatory systems in the mechanisms of disease development and stabilization.
About the Authors
N. V. Ivanov
Endocrinology Department of the North-West State Medical University named after I.I. Mechnikov, Hospital of St Elizabeth, 14 Vavilovykh st., St Petersburg, Russia, 195273
Russian Federation
Russian Federation
MD, PhD, an Associate Professor at the Endocrinology Department of theNorth-West State Medical University named after I.I. Mechnikov
S. N. Fogt
Endocrinology Department of the North-West State Medical University named after I.I. Mechnikov, Hospital of St Elizabeth, 14 Vavilovykh st., St Petersburg, Russia, 195273
Russian Federation
Russian Federation
N. V. Khudyakova
Petersburg State University, St Petersburg
Russian Federation
Russian Federation
References
1. Иванов Н.В. Функциональное состояние системы гипофиз-гонады у мужчин с артериальной гипертензией: дис. … канд. мед. наук. — СПб.: Изд-во ГОУ ДПО МАПО, 2006. — 56 с. / Ivanov N.V. Functional state of the pituitarygonadal system in men with hypertension. — St Petersburg: Publishing House of the Academy of Postgraduate Studies, 2006. — 56 р. [Russian].
2. Шишкин А.Н., Худякова Н.В., Темная Н.В., Смирнов В.В. Влияние ожирения на ремоделирование миокарда у женщин в перименопаузе // Вестн. СПб. Ун-та. — 2013. — Т. 11, № 4. — С. 13–22. / Shishkin A.N., Khudiakova N.V., Temnaya N.V., Smirnov V.V. Effect of obesity on myocardial remodeling in perimenopausal women // Bulletin of St Petersburg State University [Vestnik Sankt-Peterburgskogo Universiteta]. — 2013. — Vol. 11, № 4. — P. 13–22 [Russian].
3. Иванов Н.В., Сильницкий П.А., Ворохобина Н.В. Нарушения репродуктивной функции у мужчин с метаболическим синдромом // Балтийский журнал современной эндокринологии — 2011. — № 2. — С. 98–105. / Ivanov N.V., Silnitsky P.A., Vorohobina N.V. Reproductive dysfunction in men with metabolic syndrome // Baltic Journal of Contemporary Endocrinology [Baltiiskii Zhurnal Sovremennoi Endokrinologii]. — 2011. — № 2. — P. 98–105 [Russian].
4. Иванов Н.В., Чурина С.К. Антигипертензивная терапия и репродуктивная функция мужчин // Балтийский журнал современной эндокринологии. — 2011. № 2. — С. 106–111. / Ivanov N.V., Churina S.K. Antihypertensive therapy and male reproductive function // Baltic Journal of Contemporary Endocrinology [Baltiiskii Zhurnal Sovremennoi Endokrinologii]. — 2011. — № 2. — P. 106–111 [Russian].
5. Иванов Н.В., Ворохобина Н.В., Выходцев С.В., Акимов А.Н. Влияние гипотензивной терапии на половую функцию мужчин с артериальной гипертензией // Профилактическая и клиническая медицина. — 2005. — № 1. — С. 123–126. / Ivanov N.V., Vorohobina N.V., Vyhodtsev S.V., Akimov A.N. Effect of antihypertensive therapy on sexual function in men with hypertension // Preventive and Clinical Medicine [Profilakticheskaia i Klinicheskaia Meditsina]. — 2005. — № 1. — P. 123–126 [Russian].
6. Худякова Н.В. Сравнительная оценка влияния компонентов метаболического синдрома на сердечно-сосудистую систему у женщин в перименопаузе: дис. канд. мед. наук. — СПб.: Изд-во СПбГУ, 2014. — [Электронный ресурс]. — URL: http://spbu.ru/science/disser/soiskatelyu-uchjonoj-stepeni/dis-list/ details/14/107 / Khudiakova N.V. Comparative evaluation of the impact of metabolic syndrome components on the cardiovascular system in perimenopausal women. — St Petersburg University Publishing House, 2014. — [Electronic resource]. — URL: http:// spbu.ru/science/disser/soiskatelyu-uchjonoj-stepeni/dis-list/ details/14/107 [Russian].
7. Sun B., Shao Y., Li J. et al. Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up // Zhonghua Yi Xue Za Zhi. — 2014. — Vol. 94, № 12. — P. 913–918.
8. Adimi Z., Liew D., Gorelik A. et al. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data // Int. J. Cardiol. — 2014. — Vol. 175, № 1. — Р. 72–7. doi: 10.1016/j.ijcard.2014.04.230.
9. Lu J., Ling Z., Chen W. et al. Effects of renal sympathetic denervation using saline-irrigated radiofrequency ablation catheter on the activity of the renin-angiotensin system and endothelin-1 // J. Renin Angiotensin Aldosterone Syst. — 2014. — Feb 4. [Epub ahead of print].
10. Mancia G., Grassi G. The autonomic nervous system and hypertension // Circ. Res. — 2014. — Vol. 114, № 11. — P. 1804–1814.
11. Pradhan N., Rossi N. Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension // Curr. Hypertens. Rev. — 2013. — Vol. 9, № 2. — P. 121–129.
12. Harrison D.G., Guzik T.J., Lob H. Inflammation, immunity and hypertension // Hypertension. — 2011. — Vol. 57, № 2. — P. 132–140.
13. Harrison D.G., Vinh A., Lob H., Madhur M.S. Role of the adaptive immune system in hypertension // Curr. Opin. Pharmacol. — 2010. — Vol. 10, № 2. — P. 203–207.
14. Januszewicz W., Kabat M., Prejbisz A., Januszewicz A. Patogenesis of essential hypertension — a half of the century perspective // Pol. Merkur. Lekarski. — 2014. — Vol. 36, № 211. — P. 7–10.
15. Galkina E., Ley R. Immune and inflammatory mechanisms of atherosclerosis // Annu. Rev. Immunol. — 2009. — Vol. 27. — P. 165–197.
16. Малахов В.А., Завгородняя А.Н., Лычко В.С. и др. Проблема оксиду азоту в неврології: Монографія. Суми: Видавництво СумДПУ ім. А.С. Макаренка. — 2009. — 242 с. / Malakhov V.A., Zavgorodnyaya A.N., Lichko V.S. et al. The role of nitric oxide in neurology. Monograph. — Sumi: Publishing company of SumDPU n.a. A.S. Makarenko, 2009. — 242 р. [Ukrainian].
17. Pacurari M., Kafoury R., Tchounwou P.B. The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling // Intern. J. Inflam. — 2014. Vol. 2014. — Article ID 689360. — 13 p. — [Electronic resource]. — URL: http://dx.doi. org/10.1155/2014/689360.
18. Han Y., Runge M. S., Brasier A. R., Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κb transcription factors // Circ. Res. — 1999. — Vol. 84, № 6. — P. 695–703.
19. Landry D. B., Couper L. L., Bryant S. R., Lindner V. Activation of the NF-κB and Iκ B system in smooth muscle cells after rat arterial injury: induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 // Am. J. Pathol. — 1997. — Vol. 151, №.4. — P. 1085–1095.
20. Leung T.M., Tipoe G.L., Liong E.C. et al. Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis // Int. J. Exp. Pathol. — 2008. — Vol. 89, № 4. — P. 241–250.
21. Chakrabarti S., Lekontseva O., Davidge S.T. Estrogen is a modulator of vascular inflammation // IUBMB Life. — 2008. — Vol. 60, № 6. — P. 376–382.
22. Becher U.M., Endtmann C., Tiyerili V. Endothelial damage and regeneration: the role of the renin-angiotensin- aldosterone system // Curr. Hypertens. Rep. — 2011. — Vol. 13, № 1. — P. 86–92.
23. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis // J. Mol. Cell. Cardiol. — 2001. — Vol. 33, № 9. — P. 1673–1690.
24. Fernandaz-Parton C., Zouki C., Whittal R. et al. Matrix metalloproteinases regulate neutrophilendothelial cell adhesion through generation of endothelin-1 // FASEB J. — 2001. — Vol. 15, № 12. — P. 2230–2240.
25. Keeley E.C., Mehrad B., Strieter M.S. Fibrocytes: bringing new insights of inflammation and fibrosis // Int. J. Biochem. Cell. Diol. 2010. — Vol. 42, № 4. — P. 535–542.
26. Reilkoff R.A. Fibrocytes: emerging effector cells in chronic inflammation // Nat. Rev. Immunol. — 2011. — Vol. 11, № 6. — P. 427–435.
27. Pedram A., Razandi M., Omahony F. et al. Estrogen receptor-b prevents cardiac fibrosis // Mol. Endocrinol. — 2010. — Vol. 24, № 11. — P. 2152–2165.
28. Nguyen G., Delarue F., Burckĺe C. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin // J. Clin. Invest. — 2002. — Vol. 109, №11. — P. 1417–1427.
29. Chen X.-L., Tummala P.E., Olbryh M. et al. Angiotensin 2 induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cell // Circ. Res. — 1998. — Vol. 83, № 9. — Р. 952–959.
30. Huang Y., Noble N.A., Zhang J. et al. Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells // Kidney Intern. — 2007. — Vol. 72, № 1. — Р. 45–52.
31. Dzau V.J. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses // J. Hypertens. — 1989. — Vol. 7, № 12. — P. 933-936.
32. Wintroub B.U., Schechter N.B., Lazarus G.S., Kaempfer C.E., Schwartz L.B. Angiotensin I conversion by human and rat chymotryptic proteinases // J. Invest. Dermatol. — 1984. — Vol. 83, № 5. — P. 336–339.
33. Balcells E., Meng Q.C., Johnson W.H. Jr., Oparil S., Dell'Italia L.J. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations // Am. J. Physiol. — 1997. — Vol. 273, № 4, Pt. 2. — P. H1769– H1774.
34. Levick S.P., Melendez G.C., Plante E. et al. Cardiac mast cells: the centrepiece in adverse myocardial remodeling // Cardiovasc. Res. — 2011. — Vol. 89, № 1. — P. 12–9.
35. Kennedy S., Wu J., Wadsworth R.M. et al. Mast cells and vascular diseases // Pharmacol. Ther. — 2013. — Vol. 138, № 1. — P. 53–65.
36. Theoharides T.C., Alysandratos K.-D., Angelidou A. et al. Mast cells and inflammation // Biochim. Biophys. Acta. — 2012. — Vol. 1822, № 1. — P. 21–33.
37. Pueyo M.E., Gonzalez W., Nicoletti A. et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress // Arterioscl. Thromb. Vasc. Biol. — 2000. — Vol. 20, № 3. — P. 645–651.
38. Kranzhofer R., Schmidt J., Pfeiffer C.A. et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells // Arterioscl. Thromb. Vasc. Biol. — 1999. — Vol. 19, № 7. — P. 1623–1629.
39. Hahn A.W., Jonas U., Bühler F.R., Resink T. J. Activation of human peripheral monocytes by angiotensin II // FEBS Letters. — 1994. — Vol. 347, № 2–3. — P. 178–180.
40. Franco M., Martinez F., Quiroz Y. et.al. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension // Am. J. Physiol. Regul. Integr. Comp. Physiol. — 2007. — Vol. 293, № 1. — P. 251–256.
41. Wassmann S., Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease // J. Hypertens. — 2006. — Vol. 24, № 1. — P. S15–S21.
42. Капелько В.И. Внеклеточный матрикс миокарда и его изменения при заболеваниях сердца // Кардиология. — 2000. — № 9. — С. 78–90. / Kapelko V.I. Myocardial extracellular matrix and its changes in heart disease // Cardiology [Kardiologiia]. 2000. — Vol. 9. — P. 78–90. [Russian].
43. Cognasse F., Hamzeh-Cognasse H., Chabert A. et al. Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets // BMC Immunol. — 2014. — Vol. 15, № 1. — P. 15.
44. Sherajee S.J., Fujita Y., Rafiq K. et al. Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor // Arterioscl. Thromb. Vasc. Biol. — 2012. — Vol. 32, № 2. — Р. 257–263.
45. Martinez F.A. Aldosterone inhibition and cardiovascular protection: more important than it once appeared // Cardiovasc. Drugs Ther. — 2010. — Vol. 24, № 4. — P. 345–350.
46. Волеводз Н.Н., Тощевикова А. К. СТГ и ИФР-1 при сахарном диабете: роль в патогенезе микрососудистых осложнений // Сахарный диабет. — 2001. — № 1. — С. 45–50. / Volevodz N.N., Toshchevikova A.K. GH and IGF-1 in diabetes mellitus: role in the pathogenesis of microvascular complications // Diabetes Mellitus [Sakharniy Diabet]. — 2001. — Vol. 1. — P. 45–50 [Russian].
47. Пчелин И.Ю., Шишкин А.Н., Лаптева О.А. Роль системного и локального воспаления в развитии диабетической нефропатии // Нефрология. — 2011. — Т. 15, № 4. — С. 21–26. / Pchelin I.Yu., Shishkin A.N., Laptevа O.A. Role of systemic and local inflammation in the development of diabetic nephropathy // Nephrology [Nefrologiia]. — 2011. — Vol. 15, № 4. — P. 21–26 [Russian].
48. Sakai N., Wada T., Matsushima K. et al. The reninangiotensin system contributes to renal fibrosis through regulation of fibrocytes // J. Hypertens. — 2008. — Vol. 26, № 4. — P. 780– 790.
49. Doig C.L., Bashir J., Zielinska A.E. et al. TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle // J. Endocrinol. — 2014. — Vol. 220, № 3. — P. 389–396.
50. Chapman K.E., Coutinho A.E., Zhang Z. Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation // J. Steroid. Biochem. Mol. Biol. — 2013. — Vol. 137. — P. 82–92.
51. Alfonso B., Araki T., Zumoff B. Is there visceral adipose tissue (VAT) intracellular hypercortisolism in human obesity? // Horm. Metab. Res. — 2013. — Vol. 45, № 5. — P. 329–331. 52. Pereira C.D., Azevedo I., Monteiro R., Martins M.J. 11β- Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus // Diabetes Obes. Metab. — 2012. — Vol. 14, № 10. — P. 869–681.
52. Coutinho A.E., Brown J.K., Yang F. et al. Mast cells express 11β-hydroxysteroid dehydrogenase type 1: a role in restraining mast cell degranulation // PLoS One. — 2013. — Vol. 8, № 1. — e54640 р.
Review
For citations:
Ivanov N.V., Fogt S.N., Khudyakova N.V. N euroimmunoendocrinological aspects of arterial hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2014;20(5):349-354. https://doi.org/10.18705/1607-419X-2014-20-5-349-354
Views:
1168
Email this article 